Search Results - G. Issa

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Acute appendicitis within incisional hernia sac: a unique case report by Mohamed G. Issa

    Get full text
    Article


  2. 2

    Lung Cancer and Risk Factors in Lebanon: Epidemiology, Temporal Trends, and Comparison to Countries From Different Regions in the World by Najla A. Lakkis, Umayya M. Musharafieh, Hanane G. Issa, Mona H. Osman

    Published in Cancer Control (2023-04-01)
    Get full text
    Article


  3. 3

    P695: PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN CHRONIC PHASE CML by A. Bidikian, H. Kantarjian, E. Jabbour, N. Short, F. Ravandi, G. Issa, K. Sasaki

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    PB1883: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINOTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS INDUCES DEEP REMISSIONS: EARLY RESULTS OF AN ONGOING PH... by J. Burger, M. Sivina, E. Kim, G. Issa, W. Wierda, N. Jain, P. Thompson, A. Ferrajoli

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    Antimicrobial effects of curcumin against L. monocytogenes, S. aureus, S. Typhimurium and E. coli O157:H7 pathogens in minced meat by S. Sandikci Altunatmaz, F. Yilmaz Aksu, G. Issa, B. Basaran Kahraman, D. Dulger Altiner, S.K. Buyukunal

    Published in Veterinární Medicína (2016-05-01)
    Get full text
    Article


  6. 6

    PB1904: TRIAL IN PROGRESS: A PHASE III STUDY OF ASCIMINIB VS AN INVESTIGATOR-SELECTED TKI IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) by T. Hughes, J. Cortes, N. Takahashi, R. Larson, G. Issa, F. Bombaci, N. Ramscar, S. Kapoor, S. Ifrah, A. Hochhaus

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  7. 7

    Unveiling the genomic landscape of possible metastatic malignant transformation of teratoma secondary to cisplatin-chemotherapy: a Tempus gene analysis-based case report literature... by Christian M. Farag, Elena K. Johnston, Ryan M. Antar, Shaher G. Issa, Qasim Gadiwalla, Zoon Tariq, Sun A. Kim, Michael J. Whalen

    Published in Frontiers in Oncology (2023-06-01)
    Get full text
    Article


  8. 8

    Epidemiology of Breast, Corpus Uteri, and Ovarian Cancers in Lebanon With Emphasis on Breast Cancer Incidence Trends and Risk Factors Compared to Regional and Global Rates by Najla A. Lakkis MD, MPH, Reem M. Abdallah MD, Umayya M. Musharrafieh MD, Hanane G. Issa MS, Mona H. Osman MD, MPH, MBA

    Published in Cancer Control (2024-02-01)
    Get full text
    Article


  9. 9

    P703: ASSOCIATION BETWEEN BARIATRIC SURGERY AND OUTCOMES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH ORAL TYROSINE KINASE INHIBITORS by F. Haddad, H. Kantarjian, E. Jabbour, N. Short, A. Bidikian, J. Ning, L. Xiao, N. Pemmaraju, K. Marx, F. Ravandi, K. Sasaki, G. Issa

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  10. 10

    Manchester Intermittent and Daily diet Type 1 Diabetes App Study (MIDDAS-Type 1): protocol for a randomised feasibility trial of an intermittent and continuous low-energy diet in p... by James Yates, Basil G Issa, Jane Davies, Michelle Harvie, Suzanne Krizak, Sarah McDiarmid, Azza Aglan, Hannah Winterbottom, Womba Mubita, Amanda Hulme, Diane Perry

    Published in BMJ Open (2023-07-01)
    Get full text
    Article


  11. 11

    Adrenal lesions found incidentally: how to improve clinical and cost-effectiveness by Fahmy W F Hanna, Basil G Issa, Anthony A Fryer, Simon C Lea, Cherian George, Anurag Golash, Mike Firn, Seyi Ogunmekan, Elloise Maddock, Julius Sim, Georgios Xydopoulos, Richard Fordham

    Published in BMJ Open Quality (2020-01-01)
    Get full text
    Article


  12. 12

    Manchester Intermittent Diet in Gestational Diabetes Acceptability Study (MIDDAS-GDM): a two-arm randomised feasibility protocol trial of an intermittent low-energy diet (ILED) in... by Sarah Mackie, Ting-Li Su, James Yates, Basil G Issa, Brian McMillan, Michelle Harvie, Andrea Pilkington, Fahmy Hanna, Avni Vyas, Cheryl Lombardelli, Womba Mubita, Elizabeth Dapre, Benjamin Evans

    Published in BMJ Open (2024-02-01)
    Get full text
    Article


  13. 13

    P372: DISMAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER FAILURE OF BOTH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB by W. Macaron, E. Jabbour, M. Konopleva, F. Ravandi, N. Jain, G. Issa, T. Kadia, K. Sasaki, P. Kebriaei, M. Yilmaz, P. Thompson, K. Takahashi, H. Abbas, W. Wierda, R. Garris, H. Kantarjian, N. Short

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  14. 14

    P495: PHASE 2 STUDY OF ASTX727 (DECITABINE/CEDAZURIDINE) PLUS VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) OR PREVIOUSLY UNTREATED, ELDERLY PATIENTS... by T. Abuasab, Y. Alvarado, G. Issa, R. Islam, N. Short, M. Yilmaz, N. jain, L. Masarova, S. Kornblau, E. Jabbour, N. Pemmaraju, G. Montalban-Bravo, S. Pierce, C. DiNardo, T. Kadia, N. Daver, M. Konopleva, G. Garcia-Manero, F. Ravandi

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  15. 15

    P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBL... by F. Ravandi, E. Jabbour, N. Jain, T. Kadia, B. Gautam, M. Konopleva, W. Wierda, J. Burger, G. Issa, A. Maiti, H. Balkin, M. Kelly, R. Garris, P. Kebriaei, A. Ferrajoli, G. Garcia-Manero, Y. Alvarado, N. Short, H. Kantarjian

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  16. 16

    Prevention Of Breast and Endometrial cancer using Total Diet Replacement (PROBE-TDR) trial: protocol for a randomised controlled trial by Robert Clarke, Emma J Crosbie, Basil G Issa, John Belcher, Helen Clarke, Anthony Howell, Michelle Harvie, Hannah Harrison, Cheryl Lombardelli, Suzanne Krizak, Katharine Sellers, Yit Y Lim, Caroline Parkin, Shruthi Patel, Anthony J Maxwell, Julie Wisely, Sacha J Howell

    Published in BMJ Open (2022-07-01)
    Get full text
    Article


  17. 17

    S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDY by N. Short, H. Kantarjian, M. Konopleva, N. Jain, F. Ravandi, X. Huang, W. Macaron, W. Wierda, G. Borthakur, T. Kadia, K. Sasaki, G. Issa, G. Montalban-Bravo, Y. Alvarado, G. Garcia-Manero, C. Dinardo, J. Thankachan, R. Delumpa, E. Mayor, W. Deen, A. Milton, J. Rivera, L. Waller, C. Loiselle, R. Garris, E. Jabbour

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  18. 18

    B08 | UPDATED RESULTS AND LONGER FOLLOW-UP FROM THE AUGMENT-101 PHASE 2 STUDY OF REVUMENIB IN ALL PATIENTS WITH RELAPSED OR REFRACTORY KMT2AR ACUTE LEUKEMIA by C. Papayannidis, I. Aldoss, G. Issa, J. Blachly, M. Thirman, G. Mannis, M. Arellano, J. Dipersio, E. Traer, M. Zwaan, N. Shukla, B. Cuglievan, C. Grove, M. Greenwood, C. Mcmahon, A. Perl, R. Stone, D. Dickens, M. Heiblig, A. Žučenka, P. Montesinos, I. Mantzaris, T. Kovacsovics, P. Shami, L. Yu, R. Bagley, A. Smith, E. Stein

    Published in Haematologica (2025-09-01)
    Get full text
    Article


Search Tools: